Eagle Health Investments Lp Top Holdings and 13F Report (2025) About Eagle Health Investments LpInvestment ActivityEagle Health Investments Lp has $385.10 million in total holdings as of March 31, 2025.Eagle Health Investments Lp owns shares of 20 different stocks, but just 11 companies or ETFs make up 80% of its holdings.Approximately 15.36% of the portfolio was purchased this quarter.About 9.55% of the portfolio was sold this quarter.This quarter, Eagle Health Investments Lp has purchased 18 new stocks and bought additional shares in 4 stocks.Eagle Health Investments Lp sold shares of 5 stocks and completely divested from 2 stocks this quarter.Largest Holdings argenx $44,383,956Natera $39,561,427ICON Public $36,606,158Insmed $33,819,357Illumina $27,242,262 Largest New Holdings this Quarter 30063P105 - Exact Sciences $16,824,659 Holding00973Y108 - Akero Therapeutics $9,164,672 Holding04351P101 - Ascendis Pharma A/S $8,806,090 Holding92764N102 - Vir Biotechnology $1,558,440 Holding Largest Purchases this Quarter Exact Sciences 388,650 shares (about $16.82M)Akero Therapeutics 226,400 shares (about $9.16M)Ascendis Pharma A/S 56,500 shares (about $8.81M)Neurocrine Biosciences 70,100 shares (about $7.75M)DexCom 82,370 shares (about $5.63M) Largest Sales this Quarter Inspire Medical Systems 55,482 shares (about $8.84M)Natera 60,000 shares (about $8.48M)Insmed 70,400 shares (about $5.37M)Alnylam Pharmaceuticals 10,600 shares (about $2.86M)BioMarin Pharmaceutical 36,600 shares (about $2.59M) Sector Allocation Over TimeMap of 500 Largest Holdings ofEagle Health Investments Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorARGXargenx$44,383,9560.0%74,99011.5%MedicalNTRANatera$39,561,427$8,484,600 ▼-17.7%279,76410.3%MedicalICLRICON Public$36,606,1580.0%209,1909.5%MedicalINSMInsmed$33,819,357$5,370,816 ▼-13.7%443,3008.8%MedicalILMNIllumina$27,242,2620.0%343,3617.1%MedicalBMRNBioMarin Pharmaceutical$27,046,842$2,587,254 ▼-8.7%382,6127.0%MedicalNBIXNeurocrine Biosciences$24,896,060$7,753,060 ▲45.2%225,1006.5%MedicalDXCMDexCom$24,374,135$5,625,047 ▲30.0%356,9216.3%MedicalRAREUltragenyx Pharmaceutical$22,725,3960.0%627,6005.9%MedicalALNYAlnylam Pharmaceuticals$17,728,433$2,862,212 ▼-13.9%65,6564.6%MedicalPRCTPROCEPT BioRobotics$17,424,925$3,845,160 ▲28.3%299,0894.5%MedicalEXASExact Sciences$16,824,659$16,824,659 ▲New Holding388,6504.4%MedicalINSPInspire Medical Systems$12,920,953$8,837,173 ▼-40.6%81,1213.4%MedicalAGIOAgios Pharmaceuticals$9,693,3190.0%330,8302.5%MedicalAKROAkero Therapeutics$9,164,672$9,164,672 ▲New Holding226,4002.4%MedicalASNDAscendis Pharma A/S$8,806,090$8,806,090 ▲New Holding56,5002.3%MedicalTMDXTransMedics Group$6,772,472$5,557,328 ▲457.3%100,6611.8%MedicalISRGIntuitive Surgical$2,174,2350.0%4,3900.6%MedicalVIRVir Biotechnology$1,558,440$1,558,440 ▲New Holding240,5000.4%MedicalIMCRImmunocore$1,373,7210.0%46,3000.4%MedicalUTHRUnited Therapeutics$0$7,692,618 ▼-100.0%00.0%MedicalGRAIL INC$0$948,263 ▼-100.0%00.0%COMShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
